BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 17174600)

  • 1. Effects of applying a standardised management algorithm for moderate to severe renal dysfunction in patients with chronic stable heart failure.
    de Silva R; Nikitin NP; Witte KK; Rigby AS; Loh H; Nicholson A; Bhandari S; Clark AL; Cleland JG
    Eur J Heart Fail; 2007 Apr; 9(4):415-23. PubMed ID: 17174600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology, associated factors, and prognostic outcomes of renal artery stenosis in chronic heart failure assessed by magnetic resonance angiography.
    de Silva R; Loh H; Rigby AS; Nikitin NP; Witte KK; Goode K; Bhandari S; Nicholson A; Clark AL; Cleland JG
    Am J Cardiol; 2007 Jul; 100(2):273-9. PubMed ID: 17631082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
    Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
    Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Renal failure is an independent predictor of mortality in hospitalized heart failure patients and is associated with a worse cardiovascular risk profile].
    Grigorian Shamagian L; Varela Román A; Pedreira Pérez M; Gómez Otero I; Virgós Lamela A; González-Juanatey JR
    Rev Esp Cardiol; 2006 Feb; 59(2):99-108. PubMed ID: 16540030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure and chronic kidney disease.
    Berger AK; Duval S; Manske C; Vazquez G; Barber C; Miller L; Luepker RV
    Am Heart J; 2007 Jun; 153(6):1064-73. PubMed ID: 17540211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspirin use and outcomes in a community-based cohort of 7352 patients discharged after first hospitalization for heart failure.
    McAlister FA; Ghali WA; Gong Y; Fang J; Armstrong PW; Tu JV
    Circulation; 2006 Jun; 113(22):2572-8. PubMed ID: 16735672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of renal dysfunction over 6 months in patients with chronic heart failure due to left ventricular systolic dysfunction: contributing factors and relationship to prognosis.
    de Silva R; Nikitin NP; Witte KK; Rigby AS; Goode K; Bhandari S; Clark AL; Cleland JG
    Eur Heart J; 2006 Mar; 27(5):569-81. PubMed ID: 16364971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute kidney injury and outcomes in acute decompensated heart failure: evaluation of the RIFLE criteria in an acutely ill heart failure population.
    Hata N; Yokoyama S; Shinada T; Kobayashi N; Shirakabe A; Tomita K; Kitamura M; Kurihara O; Takahashi Y
    Eur J Heart Fail; 2010 Jan; 12(1):32-7. PubMed ID: 20023042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of renal function on the use of guideline-recommended therapies for patients with heart failure.
    Heywood JT; Fonarow GC; Yancy CW; Albert NM; Curtis AB; Stough WG; Gheorghiade M; McBride ML; Mehra MR; O'Connor CM; Reynolds D; Walsh MN
    Am J Cardiol; 2010 Apr; 105(8):1140-6. PubMed ID: 20381667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure: an observational study of treatment rates and clinical outcome.
    Gotsman I; Rubonivich S; Azaz-Livshits T
    Isr Med Assoc J; 2008 Mar; 10(3):214-8. PubMed ID: 18494235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The degree of inflammation and endothelial dysfunction in treatment of chronic heart failure in patients with coronary artery disease].
    Sazhina EIu; Kozlova IV; Rebrov AP; Al'tshuler MIu
    Klin Med (Mosk); 2006; 84(12):20-4. PubMed ID: 17294877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of aldosterone receptor blockade in patients with mild-moderate heart failure taking a beta-blocker.
    Berry C; Murphy NF; De Vito G; Galloway S; Seed A; Fisher C; Sattar N; Vallance P; Hillis WS; McMurray J
    Eur J Heart Fail; 2007 Apr; 9(4):429-34. PubMed ID: 17126073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease.
    Ezekowitz J; McAlister FA; Humphries KH; Norris CM; Tonelli M; Ghali WA; Knudtson ML;
    J Am Coll Cardiol; 2004 Oct; 44(8):1587-92. PubMed ID: 15489090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic value of renal dysfunction in patients with chronic heart failure: 12-month follow-up.
    Roik M; Starczewska MH; Stawicki S; Solarska-Półchłopek A; Warszawik O; Oreziak A; Kochanowski J; Kosior D; Opolski G
    Kardiol Pol; 2006 Jul; 64(7):704-11; discussion 712. PubMed ID: 16886127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of impaired renal function on mortality in patients with acutely decompensated chronic heart failure.
    Vaz Pérez A; Otawa K; Zimmermann AV; Stockburger M; Müller-Werdan U; Werdan K; Schmidt HB; Ince H; Rauchhaus M
    Eur J Heart Fail; 2010 Feb; 12(2):122-8. PubMed ID: 20083622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic and therapeutic challenges in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure.
    Le Jemtel TH; Padeletti M; Jelic S
    J Am Coll Cardiol; 2007 Jan; 49(2):171-80. PubMed ID: 17222727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Worsening renal failure in older chronic kidney disease patients with renal artery stenosis concurrently on renin angiotensin aldosterone system blockade: a prospective 50-month Mayo-Health-System clinic analysis.
    Onuigbo MA; Onuigbo NT
    QJM; 2008 Jul; 101(7):519-27. PubMed ID: 18375475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between heart failure treatment and development of worsening renal function among hospitalized patients.
    Butler J; Forman DE; Abraham WT; Gottlieb SS; Loh E; Massie BM; O'Connor CM; Rich MW; Stevenson LW; Wang Y; Young JB; Krumholz HM
    Am Heart J; 2004 Feb; 147(2):331-8. PubMed ID: 14760333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of angiotensin converting enzyme inhibition on renal function in the treatment of heart failure.
    Levine TB
    Clin Ther; 1989; 11(4):495-502. PubMed ID: 2673517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensity and focus of heart failure disease management after hospital discharge.
    Shah MR; Flavell CM; Weintraub JR; Young MA; Hasselblad V; Fang JC; Nohria A; Lewis EF; Givertz MM; Mudge G; Stevenson LW
    Am Heart J; 2005 Apr; 149(4):715-21. PubMed ID: 15990758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.